Meiji Yasuda Life Insurance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.21M | Buy |
15,875
+2,570
| +19% | +$360K | 0.08% | 68 |
|
|
2025
Q4 | $1.63M | Buy |
13,305
+7,770
| +140% | +$944K | 0.05% | 99 |
|
|
2025
Q3 | $614K | Buy |
5,535
+1,035
| +23% | +$118K | 0.02% | 171 |
|
|
2025
Q2 | $499K | Sell |
4,500
-1,514
| -25% | -$161K | 0.01% | 190 |
|
|
2025
Q1 | $674K | Buy |
6,014
+2,945
| +96% | +$304K | 0.01% | 176 |
|
|
2024
Q4 | $283K | Buy |
+3,069
| New | +$276K | 0.01% | 227 |
|
|
2024
Q3 | – | Sell |
-3,166
| Closed | -$217K | – | 238 |
|
|
2024
Q2 | $217K | Sell |
3,166
-43,909
| -93% | -$2.93M | ﹤0.01% | 238 |
|
|
2024
Q1 | $3.45M | Sell |
47,075
-7,742
| -14% | -$595K | 0.07% | 78 |
|
|
2023
Q4 | $4.44M | Buy |
54,817
+14,231
| +35% | +$1.11M | 0.1% | 59 |
|
|
2023
Q3 | $3.04M | Buy |
40,586
+11,423
| +39% | +$879K | 0.08% | 69 |
|
|
2023
Q2 | $2.25M | Buy |
29,163
+6,192
| +27% | +$494K | 0.06% | 84 |
|
|
2023
Q1 | $1.91M | Buy |
22,971
+240
| +1% | +$19.9K | 0.04% | 98 |
|
|
2022
Q4 | $1.95M | Buy |
22,731
+3,800
| +20% | +$301K | 0.04% | 88 |
|
|
2022
Q3 | $1.17M | Hold |
18,931
| – | – | 0.03% | 125 |
|
|
2022
Q2 | $1.17M | Buy |
18,931
+3,795
| +25% | +$235K | 0.02% | 124 |
|
|
2022
Q1 | $900K | Sell |
15,136
-326
| -2% | -$20.8K | 0.02% | 160 |
|
|
2021
Q4 | $1.12M | Sell |
15,462
-974
| -6% | -$67.1K | 0.02% | 139 |
|
|
2021
Q3 | $1.15M | Sell |
16,436
-1,486
| -8% | -$104K | 0.02% | 143 |
|
|
2021
Q2 | $1.23M | Hold |
17,922
| – | – | 0.02% | 138 |
|
|
2021
Q1 | $1.16M | Sell |
17,922
-541
| -3% | -$34.9K | 0.02% | 140 |
|
|
2020
Q4 | $1.08M | Sell |
18,463
-5,848
| -24% | -$353K | 0.02% | 141 |
|
|
2020
Q3 | $1.54M | Sell |
24,311
-414
| -2% | -$28.7K | 0.03% | 115 |
|
|
2020
Q2 | $1.9M | Buy |
24,725
+4,401
| +22% | +$337K | 0.07% | 86 |
|
|
2020
Q1 | $1.52M | Sell |
20,324
-4,652
| -19% | -$321K | 0.3% | 83 |
|
|
2019
Q4 | $1.62M | Sell |
24,976
-2,666
| -10% | -$174K | 0.22% | 112 |
|
|
2019
Q3 | $1.75M | Buy |
27,642
+1,090
| +4% | +$71.3K | 0.25% | 107 |
|
|
2019
Q2 | $1.79M | Sell |
26,552
-5,470
| -17% | -$360K | 0.26% | 99 |
|
|
2019
Q1 | $2.08M | Sell |
32,022
-3,681
| -10% | -$245K | 0.32% | 78 |
|
|
2018
Q4 | $2.23M | Sell |
35,703
-3,975
| -10% | -$278K | 0.35% | 70 |
|
|
2018
Q3 | $3.06M | Buy |
39,678
+9,250
| +30% | +$699K | 0.38% | 64 |
|
|
2018
Q2 | $2.16M | Buy |
30,428
+470
| +2% | +$33.2K | 0.3% | 89 |
|
|
2018
Q1 | $2.26M | Sell |
29,958
-11,500
| -28% | -$914K | 0.35% | 59 |
|
|
2017
Q4 | $2.97M | Buy |
41,458
+980
| +2% | +$74.4K | 0.41% | 49 |
|
|
2017
Q3 | $3.28M | Sell |
40,478
-1,300
| -3% | -$99.4K | 0.48% | 40 |
|
|
2017
Q2 | $2.96M | Buy |
41,778
+200
| +0.5% | +$13.3K | 0.45% | 44 |
|
|
2017
Q1 | $2.82M | Buy |
41,578
+500
| +1% | +$35.2K | 0.44% | 46 |
|
|
2016
Q4 | $2.94M | Sell |
41,078
-4,360
| -10% | -$324K | 0.49% | 40 |
|
|
2016
Q3 | $3.6M | Sell |
45,438
-3,310
| -7% | -$269K | 0.48% | 50 |
|
|
2016
Q2 | $4.07M | Sell |
48,748
-1,360
| -3% | -$121K | 0.65% | 33 |
|
|
2016
Q1 | $4.6M | Sell |
50,108
-2,900
| -5% | -$262K | 0.73% | 27 |
|
|
2015
Q4 | $5.36M | Sell |
53,008
-100
| -0.2% | -$10.4K | 0.85% | 18 |
|
|
2015
Q3 | $5.21M | Buy |
53,108
+800
| +2% | +$88.8K | 0.87% | 17 |
|
|
2015
Q2 | $6.12M | Sell |
52,308
-1,000
| -2% | -$109K | 0.95% | 13 |
|
|
2015
Q1 | $5.23M | Sell |
53,308
-2,785
| -5% | -$283K | 0.81% | 15 |
|
|
2014
Q4 | $5.29M | Buy |
56,093
+520
| +0.9% | +$53.8K | 0.78% | 18 |
|
|
2014
Q3 | $5.92M | Buy |
55,573
+2,036
| +4% | +$199K | 0.9% | 14 |
|
|
2014
Q2 | $4.44M | Buy |
53,537
+4,512
| +9% | +$351K | 0.7% | 21 |
|
|
2014
Q1 | $3.47M | Sell |
49,025
-2,455
| -5% | -$193K | 0.6% | 29 |
|
|
2013
Q4 | $3.87M | Buy |
51,480
+650
| +1% | +$45.3K | 0.65% | 23 |
|
|
2013
Q3 | $3.19M | Buy |
50,830
+1,460
| +3% | +$87.3K | 0.58% | 34 |
|
|
2013
Q2 | $2.53M | Buy |
+49,370
| New | +$2.57M | 0.46% | 44 |
|
Other funds holding GILD
VCM
VPM
Meiji Yasuda Life Insurance's GILD Position: Q1 2026 in Review
Meiji Yasuda Life Insurance increased its Gilead Sciences (GILD) stake by 19% in Q1 2026, buying an estimated $360K and bringing the position to 15,875 shares worth $2.21M. The position accounts for 0.08% of the portfolio, ranked #68.
Meiji Yasuda Life Insurance first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.12M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Meiji Yasuda Life Insurance held 15,875 shares of Gilead Sciences worth $2.21M as of Q1 2026.
- Meiji Yasuda Life Insurance bought 2,570 Gilead Sciences shares in Q1 2026, an estimated $360K.
- Gilead Sciences made up 0.08% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #68 holding.
- Meiji Yasuda Life Insurance first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Meiji Yasuda Life Insurance's Gilead Sciences position peaked at $6.12M in Q2 2015.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.